RGIN

Regenicin, Inc. RGIN

RGIN
Regenicin, Inc. VOQP
VioQuest Pharmaceuticals, Inc. QBIO
Q BioMed Inc. SCPS
Scopus BioPharma Inc. PARD
Poniard Pharmaceuticals, Inc. AOLS
Aeolus Pharmaceuticals, Inc. RCAR
RenovaCare, Inc. OZYMF
Strategic Partners A/S NNLX
NanoLogix, Inc. VAXX
Vaxxinity, Inc.

Résultat net

EBITDA

P/E Ratio

Capitalisation

Performance

Periode RGIN VOQP QBIO SCPS PARD AOLS RCAR OZYMF NNLX VAXX
6M 400.00 % 0.00 % 0.00 % -96.00 % 0.00 % 0.00 % 0.00 % 0.00 % 0.00 % 14 900.00 %
YTD 400.00 % 0.00 % 9 900.00 % 33.33 % 0.00 % -66.67 % 0.00 % 0.00 % 0.00 % 200.00 %
1Y 49 900.00 % 0.00 % 9 900.00 % 33.33 % 0.00 % -66.67 % 0.00 % 0.00 % 0.00 % 3 650.00 %
3Y 400.00 % 0.00 % -99.17 % -99.69 % -99.00 % 0.00 % -99.60 % -40.00 % 0.00 % -99.00 %
5Y -96.15 % -72.73 % -99.99 % -100.00 % -99.75 % -95.24 % -100.00 % -99.31 % -99.88 % -99.91 %
10Y -97.62 % -70.00 % -100.00 % -99.99 % -99.88 % -99.96 % -99.99 % -98.95 % -99.82 % -99.91 %
Depuis le début -99.95 % -100.00 % -99.98 % -99.99 % -100.00 % -100.00 % -99.99 % -98.95 % -99.97 % -99.91 %

Dividende